MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MH-19-0214705
Market Cap
₹934 Cr
UNIHEALTH-SM · NSE
Share Price
₹544.35
-2.03% today
Revenue
₹132 Cr
FY 2025-26 · +33.2% YoY
EBITDA
₹53.80 Cr
Margin 40.8%
Net Profit
₹25.49 Cr
FY 2025-26 · +80.4% YoY
P/E (TTM)
37.4x
P/B 4.7x
ROE
38.0%
ROCE 33.0%
Debt / Equity
0.23
Interest cover 5.4x
About Unihealth Hospitals Limited
Data last updated:
Unihealth Hospitals Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 26 February 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L85100MH2010PLC200491. Its GSTIN is 27AABCU1551C1ZR (Maharashtra). It is a listed company as per MCA records. Its shares are listed on NSE: UNIHEALTH.
The company has an authorised share capital of ₹17 Cr and a paid-up capital of ₹15.9 Cr. It was formerly known as Unihealth Consultancy Private Limited. It is led by directors including Akshay Mahendra Parmar (Managing Director) and Parag Rajnikant Shah (Whole-Time Director).
Its last annual general meeting (AGM) was held on 28 July 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at H – 13 & H – 14 Everest 9th Floor 156 Tardeo Road, Mumbai, Maharashtra, India – 400034.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹131.99 Cr, a growth of 33.2% compared to the previous year. For the same year it recorded a net profit of ₹25.49 Cr (net margin 19.3%) and EBITDA of ₹53.8 Cr (EBITDA margin 40.8%). The net worth stands at ₹137.61 Cr (up 35.8% YoY). Total assets are valued at ₹231.01 Cr (up 40.6% YoY).
The company has about 5 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: UniHealth. As per MCA filings, the company has open charges of ₹26.25 Cr and satisfied charges of ₹8.16 Cr on record. The company has 12 deals on record (6 funding rounds, 4 secondary share transfers, 1 ipo), with disclosed funding of ₹17.15 Cr; the latest was in September 2023.
Unihealth Hospitals Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-19-0214705). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website unihealthonline.com.
Company details
CIN L85100MH2010PLC200491
Registration Number 200491
Incorporation Date 26 February 2010
ROC Mumbai
Listing Status Listed (NSE: UNIHEALTH)
Company Status Active
Date of Last AGM 28 July 2026
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-19-0214705
CIN history
Unihealth Hospitals has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L85100MH2010PLC200491, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L85100MH2010PLC200491 | Current |
| U85100MH2010PTC200491 | Previous |
| U85100MH2010PLC200491 | Previous |
Key People
Akshay Mahendra Parmar Managing Director Parag Rajnikant Shah Whole-Time Director Anurag Ratan Kumar Shah Director Recognitions & Rankings of Unihealth Hospitals
Contact details
Unihealth Hospitals Limited's registered office is in Mumbai, Maharashtra.
- Social Media
- Registered AddressH – 13 & H – 14 Everest 9th Floor 156 Tardeo Road, Mumbai, Maharashtra, India – 400034
- IndustryHealthcare, Other Hospital And Medical Care Activities
Comprehensive company report
Unihealth Hospitals Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Unihealth Hospitals operates one associated brand: UniHealth. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Multi-specialty hospitals are operated as a chain across India. | unihealthonline.com |
Business activity
The main business activity of Unihealth Hospitals is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Unihealth Hospitals Limited, buy the company report.
Financials of Unihealth Hospitals Limited
FY 2025-26 filings availableUnihealth Hospitals Limited reported revenue of ₹131.99 Cr (up 33.2% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue
₹132 Cr
+33.2% YoY
EBITDA
₹53.80 Cr
+46.3% YoY
Profit After Tax
₹25.49 Cr
+80.4% YoY
Net Worth
₹138 Cr
+35.8% YoY
Total Assets
₹231 Cr
+40.6% YoY
Total Debt
₹32.74 Cr
+47.5% YoY
Revenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 132 | 99.07 | 48.75 | 43.93 | 36.83 | 26.21 | 22.23 |
| Revenue growth | +33.2% | +103.2% | +11.0% | +19.3% | +40.5% | +17.9% | - |
| EBITDA | 53.80 | 36.78 | 17.67 | 13.63 | 11.50 | 6.54 | 2.14 |
| EBITDA margin | +40.8% | +37.1% | +36.3% | +31.0% | +31.2% | +25.0% | +9.6% |
| Profit before tax | 46.30 | 30.40 | 13.64 | 9.27 | 5.19 | 5.50 | (0.92) |
| Net profit | 25.49 | 14.13 | 10.31 | 7.67 | 3.80 | 5.04 | (1.05) |
| Net profit margin | +19.3% | +14.3% | +21.2% | +17.5% | +10.3% | +19.2% | -4.7% |
| EPS (₹) | 16.45 | 9.17 | 6.69 | 55.27 | 28.47 | 37.33 | (6.31) |
| Balance sheet | |||||||
| Total assets | 231 | 164 | 101 | 66.69 | 52.58 | 49.30 | 46.33 |
| Net worth | 138 | 101 | 85.45 | 27.52 | 14.79 | 10.70 | 5.68 |
| Total debt | 32.74 | 22.20 | 15.16 | 39.27 | 38.01 | 38.71 | 40.68 |
| Cash & bank | 10.45 | 15.61 | 28.51 | 1.95 | 2.35 | 2.05 | 1.20 |
| Net working capital | 134 | 91.51 | 58.97 | 22.47 | 13.19 | 13.67 | 8.18 |
| Cash flow | |||||||
| Cash from operations | 5.69 | 3.31 | 4.56 | 1.33 | 9.27 | 4.06 | 0.66 |
| Cash from investing | (19.37) | (5.08) | 0.44 | (5.07) | (3.62) | 0.05 | (1.38) |
| Cash from financing | 15.76 | (3.16) | 21.56 | 3.35 | (5.35) | (3.25) | 1.19 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | 6.54 | 3.56 | 4.23 | 1.92 | 1.61 | 0.63 |
| Revenue growth | +83.7% | -15.8% | +120.3% | +19.3% | +155.6% | - |
| EBITDA | 2.48 | 0.25 | 1.98 | 0.56 | 0.82 | (0.31) |
| EBITDA margin | +37.9% | +7.0% | +46.8% | +29.2% | +50.9% | -49.2% |
| Profit before tax | 8.83 | 3.25 | 3.79 | 1.12 | 0.48 | (1.16) |
| Net profit | 6.49 | 2.36 | 3.04 | 1.34 | 0.48 | (1.16) |
| Net profit margin | +99.2% | +66.3% | +71.9% | +69.8% | +29.8% | -184.1% |
| EPS (₹) | 4.13 | 1.53 | 1.97 | 9.62 | 3.56 | (8.61) |
| Balance sheet | ||||||
| Total assets | 79.56 | 69.64 | 68.03 | 24.90 | 18.12 | 16.31 |
| Net worth | 79.32 | 66.72 | 64.47 | 12.67 | 6.51 | 6.03 |
| Total debt | 0.00 | 2.66 | 3.30 | 12.08 | 11.60 | 6.96 |
| Cash & bank | 3.10 | 4.16 | 26.64 | 0.04 | 0.15 | 0.10 |
| Net working capital | 9.27 | 10.05 | 30.83 | 1.16 | 2.93 | 8.53 |
| Cash flow | ||||||
| Cash from operations | 4.03 | (0.83) | (2.44) | 1.97 | 2.25 | (0.32) |
| Cash from investing | (5.41) | (8.07) | (10.50) | (7.17) | (6.13) | 0.06 |
| Cash from financing | 4.32 | (0.58) | 39.55 | 5.09 | 3.93 | 0.19 |
Financial Statements
Figures in ₹ Cr; negatives in brackets. Updated 10 Nov 2026
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 132 | 99.07 | 48.75 | 43.93 | 36.83 | 26.21 | 22.23 |
| Revenue growth | +33.2% | +103.2% | +11.0% | +19.3% | +40.5% | +17.9% | - |
| Other income | 5.02 | 2.72 | 1.60 | 2.10 | 1.09 | 2.43 | 0.88 |
| Total expenses | 78.19 | 62.29 | 31.08 | 30.30 | 25.33 | 19.67 | 20.09 |
| Employee cost | 18.25 | 14.33 | 7.33 | 6.48 | 5.79 | 4.36 | 5.22 |
| EBITDA | 53.80 | 36.78 | 17.67 | 13.63 | 11.50 | 6.54 | 2.14 |
| EBITDA margin | +40.8% | +37.1% | +36.3% | +31.0% | +31.2% | +25.0% | +9.6% |
| Depreciation | 10.18 | 5.95 | 2.26 | 2.52 | 2.21 | 2.18 | 2.19 |
| Interest | 2.34 | 3.15 | 3.37 | 3.94 | 5.19 | 1.29 | 1.75 |
| Profit before tax | 46.30 | 30.40 | 13.64 | 9.27 | 5.19 | 5.50 | (0.92) |
| Tax | 0.85 | 3.27 | 3.25 | 1.62 | 1.41 | 0.52 | 0.02 |
| Net profit | 25.49 | 14.13 | 10.31 | 7.67 | 3.80 | 5.04 | (1.05) |
| Net profit margin | +19.3% | +14.3% | +21.2% | +17.5% | +10.3% | +19.2% | -4.7% |
| EPS (₹) | 16.45 | 9.17 | 6.69 | 55.27 | 28.47 | 37.33 | (6.31) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 15.70 | 15.40 | 15.40 | 1.39 | 1.34 | 1.34 | 1.34 |
| Reserves & surplus | 120 | 85.96 | 70.05 | 26.13 | 13.45 | 9.36 | 4.34 |
| Shareholders' funds (net worth) | 138 | 101 | 85.45 | 27.52 | 14.79 | 10.70 | 5.68 |
| Minority interest | 60.35 | 40.45 | (0.25) | (0.24) | (0.22) | (0.12) | (0.03) |
| Secured loans | 19.03 | 18.57 | 8.43 | 17.21 | 18.65 | 20.71 | 21.08 |
| Unsecured loans | 13.71 | 3.63 | 6.73 | 22.06 | 19.36 | 18.00 | 19.60 |
| Total debt | 32.74 | 22.20 | 15.16 | 39.27 | 38.01 | 38.71 | 40.68 |
| Total liabilities | 231 | 164 | 101 | 66.69 | 52.58 | 49.30 | 46.33 |
| Assets | |||||||
| Gross block | 131 | 106 | 53.33 | 51.39 | 50.80 | 47.48 | 43.36 |
| Net block | 84.37 | 67.65 | 35.72 | 37.08 | 35.84 | 35.19 | 35.44 |
| Capital work in progress | 9.61 | 5.29 | 0.37 | 0.00 | 0.49 | 0.46 | 2.11 |
| Investments | 0.46 | 0.19 | 0.21 | 0.29 | 0.28 | 0.36 | 0.39 |
| Inventories | 6.84 | 4.24 | 2.08 | 2.11 | 1.80 | 1.46 | 0.75 |
| Sundry debtors | 123 | 82.16 | 33.57 | 27.39 | 18.19 | 14.19 | 12.55 |
| Cash & bank balances | 10.45 | 15.61 | 28.51 | 1.95 | 2.35 | 2.05 | 1.20 |
| Loans & advances | 15.20 | 7.28 | 2.82 | 1.78 | 1.83 | 4.54 | 5.69 |
| Total current assets | 156 | 109 | 66.98 | 33.23 | 24.17 | 22.24 | 20.19 |
| Total current liabilities | 21.84 | 17.78 | 8.01 | 10.76 | 10.98 | 8.57 | 12.01 |
| Net working capital | 134 | 91.51 | 58.97 | 22.47 | 13.19 | 13.67 | 8.18 |
| Total assets | 231 | 164 | 101 | 66.69 | 52.58 | 49.30 | 46.33 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 8.36 | 13.29 | 1.95 | 2.35 | 2.05 | 1.20 | 0.72 |
| Net cash from operating activities | 5.69 | 3.31 | 4.56 | 1.33 | 9.27 | 4.06 | 0.66 |
| Net cash from investing activities | (19.37) | (5.08) | 0.44 | (5.07) | (3.62) | 0.05 | (1.38) |
| Net cash from financing activities | 15.76 | (3.16) | 21.56 | 3.35 | (5.35) | (3.25) | 1.19 |
| Net change in cash | 2.08 | (4.93) | 26.55 | (0.40) | 0.30 | 0.85 | 0.48 |
| Closing cash | 10.45 | 15.61 | 28.51 | 1.95 | 2.35 | 2.05 | 1.20 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +33.2% | +103.2% | +11.0% | +19.3% | +40.5% | +17.9% | - |
| EBITDA growth | +46.3% | +108.2% | +29.6% | +18.5% | +75.8% | +205.6% | - |
| PBT growth | +52.3% | +122.9% | +47.1% | +78.6% | -5.6% | +9998.0% | +9997.0% |
| Net income growth | +80.4% | +37.1% | +34.4% | +101.8% | -24.6% | +580.0% | - |
| Revenue CAGR (3Y) | +44.3% | +39.1% | +23.0% | +25.5% | - | - | - |
| EBITDA CAGR (3Y) | +58.0% | +47.3% | +39.3% | +85.4% | - | - | - |
| Profitability & leverage | |||||||
| Net income margin | +34.4% | +27.4% | +21.3% | +17.4% | +10.3% | +19.0% | -4.2% |
| Return on capital employed | +33.0% | +29.9% | +20.3% | +21.3% | +18.6% | +13.4% | 0.0% |
| Return on net worth | +38.0% | +29.0% | +18.4% | +32.7% | +21.6% | +46.3% | 0.0% |
| Debt / equity | 0.23 | 0.20 | 0.48 | 1.83 | 3.01 | 4.85 | 7.16 |
| Long-term debt / equity | 0.15 | 0.12 | 0.42 | 1.69 | 2.86 | 4.40 | 6.19 |
| Interest cover | 5.36 | 10.22 | 21.87 | 35.46 | 55.87 | 29.59 | -3,500.00 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 1.11 | 1.24 | 0.93 | 0.86 | 0.75 | 0.58 | 0.51 |
| Inventory turnover | 23.82 | 31.35 | 23.27 | 22.47 | 22.60 | 23.72 | 29.64 |
| Debtors turnover | 1.28 | 1.71 | 1.60 | 1.93 | 2.27 | 1.96 | 1.77 |
| EPS (₹) | 16.45 | 9.17 | 6.69 | 55.27 | 28.47 | 37.33 | (6.31) |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 86.69 | 65.82 | 55.49 | 198.04 | 110.23 | 79.76 | 42.34 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Revenue | 6.54 | 3.56 | 4.23 | 1.92 | 1.61 | 0.63 |
| Revenue growth | +83.7% | -15.8% | +120.3% | +19.3% | +155.6% | - |
| Other income | 6.69 | 3.31 | 2.33 | 1.79 | 0.94 | 0.06 |
| Total expenses | 4.06 | 3.31 | 2.25 | 1.36 | 0.79 | 0.94 |
| Employee cost | 1.77 | 1.62 | 1.26 | 0.53 | 0.44 | 0.46 |
| EBITDA | 2.48 | 0.25 | 1.98 | 0.56 | 0.82 | (0.31) |
| EBITDA margin | +37.9% | +7.0% | +46.8% | +29.2% | +50.9% | -49.2% |
| Depreciation | 0.24 | 0.28 | 0.16 | 0.08 | 0.09 | 0.11 |
| Interest | 0.10 | 0.03 | 0.36 | 1.15 | 1.19 | 0.80 |
| Profit before tax | 8.83 | 3.25 | 3.79 | 1.12 | 0.48 | (1.16) |
| Tax | 2.34 | 0.89 | 0.75 | (0.22) | 0.00 | 0.00 |
| Net profit | 6.49 | 2.36 | 3.04 | 1.34 | 0.48 | (1.16) |
| Net profit margin | +99.2% | +66.3% | +71.9% | +69.8% | +29.8% | -184.1% |
| EPS (₹) | 4.13 | 1.53 | 1.97 | 9.62 | 3.56 | (8.61) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Equity & liabilities | ||||||
| Share capital | 15.70 | 15.40 | 15.40 | 1.39 | 1.34 | 1.34 |
| Reserves & surplus | 62.11 | 51.32 | 49.07 | 11.28 | 5.17 | 4.69 |
| Shareholders' funds (net worth) | 79.32 | 66.72 | 64.47 | 12.67 | 6.51 | 6.03 |
| Secured loans | 0.00 | 1.88 | 0.00 | 0.84 | 0.29 | 0.48 |
| Unsecured loans | 0.00 | 0.78 | 3.30 | 11.24 | 11.31 | 6.48 |
| Total debt | 0.00 | 2.66 | 3.30 | 12.08 | 11.60 | 6.96 |
| Total liabilities | 79.56 | 69.64 | 68.03 | 24.90 | 18.12 | 16.31 |
| Assets | ||||||
| Gross block | 5.00 | 5.00 | 4.66 | 2.84 | 2.84 | 2.84 |
| Net block | 2.90 | 3.14 | 3.08 | 1.42 | 1.50 | 1.60 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 30.49 | 30.50 | 18.37 | 6.34 | 6.15 | 6.15 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sundry debtors | 4.56 | 2.91 | 2.61 | 0.62 | 2.10 | 1.48 |
| Cash & bank balances | 3.10 | 4.16 | 26.64 | 0.04 | 0.15 | 0.10 |
| Loans & advances | 3.73 | 3.69 | 2.03 | 0.95 | 1.09 | 7.30 |
| Total current assets | 11.39 | 10.76 | 31.28 | 1.61 | 3.34 | 8.88 |
| Total current liabilities | 2.12 | 0.71 | 0.45 | 0.45 | 0.41 | 0.35 |
| Net working capital | 9.27 | 10.05 | 30.83 | 1.16 | 2.93 | 8.53 |
| Total assets | 79.56 | 69.64 | 68.03 | 24.90 | 18.12 | 16.31 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Opening cash | 0.16 | 9.64 | 0.04 | 0.15 | 0.10 | 0.17 |
| Net cash from operating activities | 4.03 | (0.83) | (2.44) | 1.97 | 2.25 | (0.32) |
| Net cash from investing activities | (5.41) | (8.07) | (10.50) | (7.17) | (6.13) | 0.06 |
| Net cash from financing activities | 4.32 | (0.58) | 39.55 | 5.09 | 3.93 | 0.19 |
| Net change in cash | 2.94 | (9.48) | 26.61 | (0.11) | 0.05 | (0.07) |
| Closing cash | 3.10 | 4.16 | 26.64 | 0.04 | 0.15 | 0.10 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Growth | ||||||
| Sales growth | +83.7% | -15.8% | +120.3% | +19.3% | +155.6% | - |
| EBITDA growth | +892.0% | -87.4% | +253.6% | -31.7% | +364.5% | - |
| PBT growth | +171.7% | -14.3% | +238.4% | +133.3% | +9998.0% | +9997.0% |
| Net income growth | +175.0% | -22.4% | +126.9% | +179.2% | +141.4% | - |
| Revenue CAGR (3Y) | +50.5% | +30.3% | +88.7% | - | - | - |
| EBITDA CAGR (3Y) | +64.2% | -32.7% | - | - | - | - |
| Profitability & leverage | ||||||
| Net income margin | +99.2% | +66.3% | +71.9% | +69.8% | +29.8% | -184.1% |
| Return on capital employed | +12.0% | +4.8% | +8.7% | +9.4% | +7.8% | 0.0% |
| Return on net worth | +8.9% | +3.6% | +7.7% | +10.9% | +4.9% | 0.0% |
| Debt / equity | 0.02 | 0.05 | 0.20 | 1.23 | 1.27 | 1.15 |
| Long-term debt / equity | 0.01 | 0.03 | 0.19 | 1.17 | 1.19 | 1.11 |
| Interest cover | 4.46 | -100.00 | 19.78 | 239.58 | 163.01 | -190.48 |
| Efficiency & per share | ||||||
| Fixed asset turnover | 1.31 | 0.74 | 1.13 | 0.68 | 0.57 | 0.22 |
| Inventory turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debtors turnover | 1.75 | 1.29 | 2.62 | 1.41 | 0.77 | 0.43 |
| EPS (₹) | 4.13 | 1.53 | 1.97 | 9.62 | 3.56 | (8.61) |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 49.56 | 43.33 | 41.87 | 91.17 | 48.54 | 44.97 |
To see the full year-wise statements and ratios of Unihealth Hospitals Limited, buy the company report.
Board of directors of Unihealth Hospitals Limited
Unihealth Hospitals has 5 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Parag Rajnikant Shah Also directs: Umc Hospitals Private Limited | Whole-Time Director | 16 Mar 2017 | 9 Years 7 Months | Current |
| Akshay Mahendra Parmar Also directs: Aryavarta Growth Partners LLP, Unity Forgings Private Limited, Aryavarta Trading Private Limited and 5 more | Managing Director | 26 Feb 2010 | 16 Years 8 Months | Current |
| Anurag Ratan Kumar Shah Also directs: Aryavarta Trading Private Limited, Unihealth Pharmaceuticals Private Limited, Aarzeal Technologies Private Limited and 2 more | Director | 26 Feb 2010 | 16 Years 8 Months | Current |
| Bachh Raj Nahar | Director | 14 Nov 2025 | 0 Years 11 Months | Current |
| Riddhi Sahil Javeri Also directs: Intermed Life Sciences Private Limited, Intermed Laboratories Private Limited, Azpire Pharma Private Limited and 1 more | Director | 09 May 2023 | 3 Years 6 Months | Current |
Charges & borrowings
Open charges
₹26.25 Cr
Satisfied charges
₹8.16 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Nov 2025 | 101196076 | Bank of India | ₹26.25 Cr | Open | |
| 24 Feb 2025 | 101070251 | Others | ₹2.55 Cr | Satisfied | |
| 08 Dec 2020 | 100392874 | Sidbi | ₹21.43 Lakh | Satisfied | |
| 12 Jul 2018 | 100192081 | Sidbi | ₹60 Lakh | Satisfied | |
| 14 Feb 2017 | 100080021 | Others | ₹39.2 Lakh | Satisfied |
To see the full charge records of Unihealth Hospitals Limited, buy the company report.
Total charge records: 9 View all charges
Deals & funding
Unihealth Hospitals Limited has 12 deals on record (6 funding rounds, 4 secondary share transfers, 1 ipo), with disclosed funding of ₹17.15 Cr; the latest was in September 2023.
Total deals
12
Funding rounds
6
Secondary share transfers
4
IPO
1
Rights issue
1
Disclosed funding
₹17.15 Cr
Deals on record (5 of 12)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2023 | IPO | ₹56.55 Cr | Investors: IPO - Unihealth Consultancy Limited, Saint Capital Fund, LRSD Securities Private Limited |
| Mar 2023 | Funding round | ₹5 Cr | Investors: an individual |
| May 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2019 | Secondary share transfer | Undisclosed | Seller: 3 individuals |
| Jun 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of Unihealth Hospitals Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Unihealth Hospitals Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Unihealth Hospitals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Unihealth Hospitals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCU1551C1ZR | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Unihealth Hospitals Limited, buy the company report.
Recent activity
Unihealth Hospitals Limited has 11 board changes on record since 2010: 5 appointments and 6 cessations. The latest: Bachh Raj Nahar was appointed as Director on 14 Nov 2025.
AGM
Unihealth Hospitals Limited last Annual general meeting of members was held on 28 Jul 2026 as per latest MCA records.
Filing
Unihealth Hospitals Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai I.
Charges
A charge registered on 24 Feb 2025 via Charge ID 101070251 with Others was fully satisfied on 29 Dec 2025.
Appointed
Bachh Raj Nahar was appointed as Director.
Charges
A charge with Bank Of India amounted to Rs. 26.25 Cr with Charge ID 101196076 was registered on 13 Nov 2025.
Charges
A charge with Others amounted to Rs. 2.55 Cr with Charge ID 101070251 was registered on 24 Feb 2025.
Ceased
Ajay Kumar Thakur ceased to be Additional Director.
Charges
A charge registered on 08 Dec 2020 via Charge ID 100392874 with Sidbi was fully satisfied on 12 Jan 2024.
Charges
A charge registered on 12 Jul 2018 via Charge ID 100192081 with Sidbi was fully satisfied on 23 Nov 2023.
Ceased
Harsh Sheth ceased to be Additional Director.
Ceased
Jagat Suman Shah ceased to be Additional Director.
Ceased
Riddhi Sahil Javeri ceased to be Additional Director.
20 earlier events are in the company report.
News
Frequently asked questions
Unihealth Hospitals is an active public limited company based in Mumbai, Maharashtra, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 26 February 2010 (16+ years old) and is registered under CIN L85100MH2010PLC200491. Listed on NSE: UNIHEALTH.
Unihealth Hospitals reported revenue of ₹131.99 Cr for FY 2025-26 (up 33.2% YoY) based on consolidated financials.
Unihealth Hospitals has 5 current directors:
- Akshay Mahendra Parmar - Managing Director
- Parag Rajnikant Shah - Whole-Time Director
- Anurag Ratan Kumar Shah - Director
- Bachh Raj Nahar - Director
- Riddhi Sahil Javeri - Director
The latest financial statements of Unihealth Hospitals on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 28 July 2026. Year-wise statements from 2015 are in the company report.
The GSTIN of Unihealth Hospitals is 27AABCU1551C1ZR, registered in Maharashtra.
The CIN (Corporate Identification Number) of Unihealth Hospitals is L85100MH2010PLC200491. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Unihealth Hospitals is a listed company as per MCA records. Its shares are listed on NSE (symbol: UNIHEALTH).
Unihealth Hospitals was incorporated on 26 February 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
Unihealth Hospitals has 12 deals on record (6 funding rounds, 4 secondary share transfers, 1 ipo), with disclosed funding of ₹17.15 Cr; the latest was in September 2023.
Bachh Raj Nahar was appointed as Director on 14 Nov 2025. Ajay Kumar Thakur ceased to be Additional Director on 11 Sep 2024. Harsh Sheth ceased to be Additional Director on 11 May 2023. Unihealth Hospitals has 11 board changes on record in total.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages